Whilst the NHS notes that taking up to 2,000 micrograms daily is unlikely to cause harm in most people, there is generally no benefit to consuming such excessive amounts unless treating confirmed deficiency under medical supervision
While efficacy matters, the tolerability and adverse effect profile often determines whether a treatment is suitable for long-term use
With all the expanding possible indications, the GLP-1 peptides are being prescribed off-label for many purposes, and now people are microdosing the drugs despite the lack of data
Injections are usually administered subcutaneously (under the skin), once a month, in your vets office
Common ones are mild and might include pain or redness at the injection site, mild diarrhea, or itching
However, the modest efficacy demonstrated in clinical trials indicates that AOD-9604 is not a standalone dramatic weight loss solution